Cabaletta Bio (CABA) Accumulated Expenses (2018 - 2025)

Cabaletta Bio's Accumulated Expenses history runs 8 years deep, the most recent figure standing at $9.7 million for Q4 2025.

• In Q4 2025, Accumulated Expenses rose 16.85% year-over-year to $9.7 million; the TTM figure through Dec 2025 stood at $9.7 million (up 16.85% YoY), while the FY2025 annual figure was $9.7 million, up 16.85% from the prior year.
• Accumulated Expenses was $9.7 million for Q4 2025 at Cabaletta Bio, up from $6.8 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $13.9 million in Q2 2025 to a low of $651000.0 in Q1 2021.
• Historically, Accumulated Expenses has averaged $5.1 million across 5 years, with a median of $3.7 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses soared 364.67% in 2022, then slumped 67.11% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $6.0 million in 2021, then dropped by 19.84% to $4.8 million in 2022, then surged by 62.72% to $7.9 million in 2023, then climbed by 5.43% to $8.3 million in 2024, then rose by 16.85% to $9.7 million in 2025.
• The last three Accumulated Expenses figures came in at $9.7 million (Q4 2025), $6.8 million (Q3 2025), and $13.9 million (Q2 2025), per Business Quant data.